CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Contineum Therapeutics, Inc.
Sign in to watch- Ticker
- CTNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271467257
- Phone
- (858) 333-5280
- Business address
- 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
- 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $10.44 ($43,543)
- 144 Insider Sale of Securities
- 4 Planned sale CMO & Head of Development sold 3,611 shares at $12.06 ($43,558)
- 4 Planned sale Chief Scientific Officer sold 4,170 shares at $12.23 ($51,009)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 5 of 11 · 202 filings